Methylation Status of CD44 Promoter Region in Primary Lung Cancer
1 other identifier
observational
40
1 country
1
Brief Summary
This project is to study the methylation status of the transcriptional regulatory region of CD44 gene in surgically resected NSCLC specimens and normal lung tissue, correlate the methylation status of promoter region with the expression of CD44 gene, and analyze if methylation is associated with survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedNovember 24, 2005
August 1, 2005
September 12, 2005
November 23, 2005
Conditions
Eligibility Criteria
You may qualify if:
- Non-small cell lung cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Laboratory Medicine, Nation Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
LINA LEE, MD,PhD
Department of Labrotoary Medicine, National Taiwan University Hospital Taipei
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 15, 2005
Study Start
August 1, 2005
Last Updated
November 24, 2005
Record last verified: 2005-08